Search This Blog

Wednesday, November 6, 2019

Voyager Therapeutics EPS beats by $0.32, beats on revenue

Voyager Therapeutics (NASDAQ:VYGR): Q3 GAAP EPS of -$0.41 beats by $0.32.
Revenue of $20.43M (+877.5% Y/Y) beats by $13.84M.
Shares +1.95% PM.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)